Brain cholesterol XVIII: EFFECt of methylphenidate (Ritalin) on [U-14C] glucose and [2-3H] acetate incorporation

• Published in: Proceedings of the Society for Experimental Biology and Medicine Vol. 150; no. 2; p. 525
• Main Author: Kabara, J J
• Format: Journal Article
• Language: English
• Published: United States 01.11.1975
• Subjects: Acetates - metabolism; Animals; Brain - metabolism; Cholesterol - metabolism; Glucose - metabolism; Injections, Intraperitoneal; Male; Methylphenidate - administration & dosage; Methylphenidate - pharmacology; Mice; Organ Size; Time Factors
• ISSN: 0037-9727
• DOI: 10.3181/00379727-150-39070

The effect of a single injection of methylphenidate (Ritalin, 4 mg/kg) on precursor ([2-3H]acetate and [U-14C]glucose) incorporation into brain cholesterol was studied. The drug caused a steady decrease in the concentration of brain cholesterol during the 24-hr period examined. Incorporation studies during this time with [U-14C]glucose indicated higher than normal incorporation for all time periods studied. The most significant incorporation increases took place 2 and 4 hr after drug injection. Experiments using [2-3H]acetate as the sterol precursor gave incorporation values which tended (not significantly) to be lower than control values at 2 and 4 h. The values after 12 hr were less than normal, while the 24-hr group indicated an increase to or slightly higher than normal values. These data suggest that the pharmacological effect of methylphenidate may be due to lowering of brain cholesterol levels directly or on some more basic metabolic process leading to a decreased level of membrane sterols.